Hepatocellular carcinoma is the most frequent primary liver cancer and is an important medical problem. Another consideration in primary liver cancer, such as hepatocellular carcinoma hcc and intrahepatic cholangiocarcinoma icc, is the fact that the underlying liver function can significantly impact patient survival. What are the guidelines on hepatocellular carcinoma hcc. It is one of the most common malignancies in adults, and is more common in men than women 24. Hepatocellular carcinoma hcc is an aggressive tumor that frequently occurs in the setting of chronic liver disease and cirrhosis see epidemiology and risk factors for. Aug 24, 2015 panel c shows multiple hepatocellularcarcinoma nodules arrows in a patient with childpugh class b cirrhosis, indicating intermediatestage disease. Hepatocellular carcinoma is responsible for over 12,000 deaths per year in the united states where the incidence of the disease is approximately 2. Its different from secondary liver cancers, which have spread to the liver from other organs.
Hepatocellular carcinoma hcc is a wide world prevalent hepatic disease, being the third greater cancer related death cause and most of the patients are not eligible for liver transplant. One system implemented is the american joint committee on cancer ajcc tumornodemetastasis tnm classification system. It is strongly associated with cirrhosis, from both alcohol and viral etiologies. Hepatocellular carcinoma is a cancer that starts in your liver. In hcc, there are at least a dozen options that have been proposed for staging the disease. Diagnosis, staging, and management of hepatocellular. One system implemented is the american joint committee on cancer ajcc. The tnm classification system takes into account tumor characteristics including size, number.
Hepatocellular carcinomas including fibrolamellar carcinoma are covered by this staging system not covered by this staging system are intrahepatic cholangiocarcinomas or. Diagnosis, staging, and management of hepatocellular carcinoma. Evolution of etiology, presentation, management and. Out of all the staging systems used in hcc, barcelona clinic liver cancer bclc staging system is probably the best because it takes in to account the tumor status defined by tumor size and number, presence of vascular invasion and extrahepatic spread, liver function defined either by the childpughs class and general health status of. The previous edition was titled surveillance for hepatocellular carcinoma and available until may 31st, 2018. Hepatocellular carcinoma hcc is the most common type of primary liver cancer. The current knowledge of the disease, however, prevents recommendation of a staging system that can be used worldwide. Staging and prognostic models for hepatocellular carcinoma. Early hcc is typically clinically silent, and the disease is often well advanced at the first manifestation. Several new systems have been proposed recently, and only three of them have been validated at this point. The risk of hepatocellular carcinoma, the most common type of liver cancer, is higher in people with longterm liver.
Hepatocellular carcinoma hcc is a primary malignancy of the liver. Hepatocarcinogenesis represents a multi step process in which both genetic abnormalities and epigenetic alterations encourage the malignant transformation of hepatocytes. Several classifications are currently available for tumor staging in order to. Hcc constitutes approximately 5% of all cancers partly due to the high endemic rates of hepatitis b infection 1. Llovet,1 josep fuster,2 and jordi bruix1 of the barcelonaclnic liver cancer group hepatocellular carcinoma hcc is the. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis b or hepatitis c infection. Panel c shows multiple hepatocellularcarcinoma nodules arrows in a patient with childpugh class b cirrhosis, indicating intermediatestage disease. Staging and current treatment of hepatocellular carcinoma. Accurate staging of hepatocellular carcinoma hcc is important because it provides prognostic data as well as aids in selecting patients for appropriate clinical treatment regimens 1. Hepatocellular carcinoma is the most frequent primary malignancy of the liver and appears to be rising in incidence in the united states and other developed westerm countries. Pdf hepatocellular carcinoma hcc is a major health problem with a high incidence and mortality all over the world. Learning objectives determine which patients with chronic hepatitis c infection. Mar 23, 2020 staging systems for hepatocellular carcinoma hcc have not been universally adopted. Liu ph, hsu cy, hsia cy, lee yh, su cw, huang yh, lee fy, lin hc, huo ti.
Apr 29, 2020 hepatocellular carcinoma hcc is a primary malignancy of the hepatocyte, generally leading to death within 620 months. United network for organ sharing unos recently implemented a national policy granting priority listing for liver transplantation lt in patients who achieved down. Hepatocellular carcinoma radiology reference article. Panel d shows a large mass more than 10 cm in diameter and ascites arrows, indicating advancedstage hepatocellular carcinoma.
Hepatocellular carcinoma hepatocellular carcinoma hcc is the 5th most common malignancy worldwide it is the 3rd most common cause of cancer related mortality responsible for 1 million deaths each year in the united states, over the past 20 years, the incidence of hcc has increased despite advances in screening and early. Introduction hepatocellular carcinoma hcc is a primary tumor of the liver that usually develops in the setting of chronic liver disease, particularly in patients with cirrhosis and. Hepatocellular carcinoma hcc is the most common primary liver cancer and the fourth leading cause of cancerassociated mortality in 2018 globally 1. Hepatocellular carcinoma staging classifications supersede the typical tnm staging system seen in most other epithelial cancers, as the tnm staging system has been found to not be as prognostically useful for stratification of patients with hepatocellular carcinoma. Diagnosis, staging, and treatment of hepatocellular carcinoma josep m. Diagnosis and staging of hepatocellular carcinoma hcc. Llovet,1 josep fuster,2 and jordi bruix1 of the barcelonacl.
Evidencebased diagnosis, staging, and treatment of patients with hepatocellular carcinoma jordi bruix,1 maria reig,1 and morris sherman2 1barcelona clinic liver cancer group, liver. All take into consideration not only the stage of the tumor but also the degree of hepatocellular dysfunction, which is known to. No one staging system appears optimal, but important factors to be considered are the size of. Hepatocellular carcinoma hcc usually arises in patients with cirrhosis of the liver due to any cause.
Diagnosis, staging and treatment of hepatocellular carcinoma. It links the tnm staging system see appendix a, the patients ecog performance status see appendix b, and the. Tnm staging of hepatocellular carcinomas ajcc 8th edition. Without treatment, there is a 5year survival rate of less than 5%, 1. Hepatocellular carcinoma is now the third leading cause of cancer deaths worldwide, with over. Mar 30, 2020 hepatocellular carcinoma hcc is a primary malignancy of the liver. Pdf staging of hepatocellular carcinoma researchgate. Role of 18ffluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Staging in hcc also helps to know the impact of conventional or investigational treatment and to design the prospective trials.
Discrimination value of the new western prognostic system clip score for hepatocellular carcinoma in 662 japanese patients. Hepatocellular carcinoma hcc is a primary malignancy of the hepatocyte, generally leading to death within 620 months. Jun 06, 2014 staging systems in hepatocellular carcinoma. With 782 000 cases diagnosed and 746 000 deaths in 2012, and an ageadjusted. Several substitute staging systems have arisen to guide therapy choice and. Hepatocellular carcinoma hcc is the most common primary malignancy of the liver. Not covered by this staging system are intrahepatic cholangiocarcinomas or combined hepatocellular cholangiocarcinomas use the intrahepatic bile duct tumors staging system instead. The tnm classification system takes into account tumor characteristics including size, number, and vascular invasion, as well as lymph. In contrast to other cancers, survival of patients with hcc is determined by the extent of the tumor in addition to underlying liver disease and its functional reserve. Reference aasld guideline on management of hepatocellular carcinoma aasld 2010 jul pdf synthesized recommendation grading system for dynamed dynamed systematically monitors. Staging of hepatocellular carcinoma before liver transplant. Comparison of major hepatocellular carcinoma hcc staging systems, including the recently proposed italian liver cancer ita. Hepatocellular carcinoma staging radiology reference.
Hepatocellular carcinoma is now the third leading cause of cancer deaths worldwide, with over 500,000 people affected. Hepatocellular carcinomas including fibrolamellar carcinoma are covered by this staging system not covered by this staging system are intrahepatic cholangiocarcinomas or combined hepatocellular cholangiocarcinomas use the intrahepatic bile duct tumors staging system instead. Hepatocellular carcinoma staging classifications supersede the typical tnm staging system seen in most other epithelial cancers, as the tnm staging system has been found to not be as. The suboptimal prospective clinical performance of many hcc staging systems has led to continued efforts at refinement. Hepatocellular carcinoma frequently arises in the setting of cirrhosis, ap. Staging of hepatocellular carcinoma pubmed central pmc. Staging systems for hepatocellular carcinoma hcc have not been universally adopted. The major risk factor for development of hepatocellular carcinoma is cirrhosis, particularly cirrhosis related to chronic viral hepatitis, alco. Hepatocellular carcinoma hcc is the most common type of primary liver cancer in adults, and is the most common cause of death in people with cirrhosis it occurs in the setting of chronic liver inflammation, and is most closely linked to chronic viral hepatitis infection hepatitis b or c or exposure to toxins such as alcohol or aflatoxin. The conventional staging systems for hepatocellular carcinoma hcc, such as the okuda stage or the tnm stage have shown important limitations in. Surveillance for hepatocellular carcinoma evaluation. Evidencebased diagnosis, staging, and treatment of. The conventional staging systems for hepatocellular carcinoma.
Hepatocellular carcinoma criteria bmj best practice. The conventional staging systems for hepatocellular carcinoma hcc, such as the okuda stage or the tnm stage have shown important limitations in classifying patients. Hepatocellular carcinoma hcc is the third leading cause of cancer deaths in the world. Hepatocellular carcinoma hcc is the cause of 250,000 deaths worldwide each year. Diagnosis, staging, and treatment strategy 391 between 5 and 20 mm in size that was detected during an screening ultrasound. Many staging systems have been used to provide a clinical classification in patients with hcc and as mentioned earlier the best system would be that take in to account the tumor status defined by tumor size and number, presence of vascular invasion and extrahepatic spread, liver function defined either by the childpughs class or individually. Pdf diagnosis and staging of hepatocellular carcinoma. State of the art jeanluc raoul institut paolicalmettes, marseille france esmo summit africa, cape town, 1012 february 2017. Stage information for adult primary liver cancer prognostic modeling in hepatocellular carcinoma hcc is complex because cirrhosis is involved in as many as 80% of the cases. Several classifications are currently available for tumor staging in order to determine patient prognosis. Learning objectives determine which patients with chronic hepatitis c infection should undergo hepatocellular carcinoma surveillance. Tumor features and the factors related to functional hepatic reserve must be considered. Role of the routine use of chest computed tomography and bone scan in staging workup of hepatocellular carcinoma.
1417 1193 769 393 1210 626 988 1198 1154 1464 990 983 800 1491 699 692 1484 1544 1490 271 617 109 619 1481 785 584 1164 896 963 639 316